Table 1

Characteristics of CLL patients studied

CLL patient labelApoptotic response S-US at 6 hIgVH status (%)Zap-70 statusCytogenetics
Indolent     
    CLL-M4 21.2 M-CLL VH3-23 (93) Negative Normal 
    CLL-M5 24.8 M-CLL VH3-22 (87) Negative 13q− 
    CLL-M6 19.6 M-CLL VH3-23 (92) Negative 13q− 
    CLL-M7 28.8 M-CLL VH4-31 (86) Negative 13q− 
    CLL-M3 32.5 M-CLL VH3-48 (91) Negative 13q− 
    CLL-M8 33.6 M-CLL VH4-34 (94) Negative 13q− 
    CLL-M1 ND M-CLL VH4-31 (95) Negative 13q− 
Aggressive     
    CLL-UM1 20.5 UM-CLL VH1-69 (99) Positive Add 12 
    CLL-UM2 41.7 UM-CLL VH1-69 (100) Positive t(8;13), add8, 11q− 
    CLL-UM3 41.7 UM-CLL VH1-69 (100) Positive Add 12 
    CLL-UM4 53.2 UM-CLL VH4-34 (100) Positive Normal 
    CLL-M2 44.7 M-CLL VH3-48 (97) Positive Normal 
CLL patient labelApoptotic response S-US at 6 hIgVH status (%)Zap-70 statusCytogenetics
Indolent     
    CLL-M4 21.2 M-CLL VH3-23 (93) Negative Normal 
    CLL-M5 24.8 M-CLL VH3-22 (87) Negative 13q− 
    CLL-M6 19.6 M-CLL VH3-23 (92) Negative 13q− 
    CLL-M7 28.8 M-CLL VH4-31 (86) Negative 13q− 
    CLL-M3 32.5 M-CLL VH3-48 (91) Negative 13q− 
    CLL-M8 33.6 M-CLL VH4-34 (94) Negative 13q− 
    CLL-M1 ND M-CLL VH4-31 (95) Negative 13q− 
Aggressive     
    CLL-UM1 20.5 UM-CLL VH1-69 (99) Positive Add 12 
    CLL-UM2 41.7 UM-CLL VH1-69 (100) Positive t(8;13), add8, 11q− 
    CLL-UM3 41.7 UM-CLL VH1-69 (100) Positive Add 12 
    CLL-UM4 53.2 UM-CLL VH4-34 (100) Positive Normal 
    CLL-M2 44.7 M-CLL VH3-48 (97) Positive Normal 

Indolent: average, 26.8; median, 26.8. Aggressive: average, 40.4; median, 41.7.

Apoptotic response measured by flow cytometry after Annexin V–FITC and propidium iodide double staining, with percentage of BCR-stimulated cells compared to unstimulated cells undergoing Annexin V[e]FITC staining 6 hours after BCR cross-linking. Cytogenetics characteristics were assessed by FISH.

UM indicates IgVH unmutated; M, IgVH mutated; and ND, not determined.

Close Modal

or Create an Account

Close Modal
Close Modal